Timing is everything: Executive functions in children exposed to elevated levels of phenylalanine

Neuropsychology

Volumn 17, Issue 3, 2003, Pages 458-468

  Antshel, Kevin M ^a   Waisbren, Susan E ^b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BEHAVIOR; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR ACTIVITY; PHENYLKETONURIA; PRENATAL EXPOSURE; PRIORITY JOURNAL; SCHOOL CHILD; SIBLING;

ADOLESCENT; AGE OF ONSET; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CASE-CONTROL STUDIES; CHILD; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; PHENYLALANINE; PHENYLKETONURIAS; PSYCHOMOTOR DISORDERS; TIME FACTORS; VERBAL LEARNING;

EID: 0042970444     PISSN: 08944105     EISSN: None     Source Type: Journal    
DOI: 10.1037/0894-4105.17.3.458     Document Type: Article

References (89)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. Arnold, G. L., Kramer, B. M., Kirby, R. S., Plumeau, P. B., Blakely, E. M., Sanger-Cregan, L. S., & Davidson, P. W. (1998). Factors affecting cognitive, motor, behavioral and executive functioning in children with phenylketonuria. Acta Paediatrica, 87, 565-570.
3. Axelrod, B. N., Ricker, J. H., & Cherry, S. A. (1994). Concurrent validity of the MAE visual naming test. Archives of Clinical Neuropsychology, 9, 317-321.
4. Azen, C. G., Koch, R., Friedman, E. G., Berlow, S., Caldwell, J., Krause, W., et al. (1991). Intellectual development in 12-year-old children treated for phenylketonuria. American Journal of Diseases of Children, 145, 35-39.
5. Barkley, R. A. (1997). Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychological Bulletin, 121, 65-94.
6. Barkley, R. A. (1998). Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment (2nd ed.). New York: Guilford Press.
7. Beasley, M. G., Costello, P. M., & Smith, I. (1994). Outcome of treatment in young adults with phenylketonuria detected by routine neonatal screening between 1964 and 1971. Quarterly Journal of Medicine, 87, 155-160.
8. Beck, A. T. (1967). Depression: Clinical, experimental, and theoretical aspects. New York: Hoeber.
9. Beery, K. E. (1997). The Visual-Motor Integration Test (4th edition): Administration, scoring, & teaching manual. Austin, TX: Pro-Ed.
10. Bjorklund, D. F., & Douglas, R. N. (1997). The development of memory strategies. In N. Cowan (Ed.), The development of memory in childhood (pp. 201-246). Hove, England: Psychology Press.
11. Brunner, R. L., Berch, D. B., & Berry, H. (1987). Phenylketonuria and complex spatial visualization: an analysis of information processing. Developmental Medicine and Child Neurology, 4, 460-468.
12. Brunner, R. L., & Berry, H. K. (1987). Phenylketonuria and sustained attention: The continuous performance test. International Journal of Clinical Neuropsychology, 9, 68-70.
13. Burlina, A. B., Bonafe, L., Ferrari, V., Suppiej, A., Zacchello, F., & Burlina, A. P. (2000). Measurement of neurotransmitter metabolites in the cerebrospinal fluid of phenylketonuric patients under dietary treatment. Journal of Inherited Metabolic Disease, 23, 313-316.
14. Byrne, J. M., DeWolfe, N. A., & Bawden, H. N. (1998). Assessment of attention-deficit hyperactivity disorder in preschoolers. Child Neuropsychology, 4, 49-66.
15. Carlson, C. L., Lahey, B. B., & Neeper, R. (1986). Direct assessment of the cognitive correlates of attention deficit disorders with and without hyperactivity. Journal of Psychopathology and Behavioral Assessment, 8, 69-86.
16. Carlson, C. L., & Mann, M. (2002). Sluggish cognitive tempo predicts a different pattern of impairment in the attention deficit hyperactivity disorder, predominantly inattentive type. Journal of Clinical Child and Adolescent Psychology, 31, 123-129.
17. Cleary, M. A., Walter, J. H., Wraith, J. E., Jenkins, J. P. R., Alani, S. M., Tyler, K. & Whittle, D. (1994). Magnetic resonance imaging of the brain in phenylketonuria. Lancet, 344, 87-90.
18. Cleary, M. A., Walter, J. H., Wraith, J. E., White, F., Tyler, K., & Jenkins, J. (1995). Magnetic resonance imaging in phenylketonuria: Reversal of cerebral white matter change. Journal of Pediatrics, 127, 251-255.
19. Cohen J. (1988) Statistical power analysis for the behavioural sciences (2nd ed.). New York: Academic Press.
20. Coles, C. D., Platzman, K. A., Lynch, M. E., & Friedes, D. (2001, April). Auditory and visual sustained attention in adolescents exposed to alcohol. Poster session presented at the annual meeting of the National FAS Conference, Atlanta, GA.
21. Courtney, S. M., Petit, L., Maisog, J. M., Ungerleider, L. G., & Haxby, J. V. (1998, February 27). An area specialized for spatial working memory in human frontal cortex. Science, 279, 1347-1351.
22. Delis, D. C., Kramer, J. H., Kaplan, E., & Ober, B. A. (1994). CVLT-C: California Verbal Learning Test - Children's Version. San Antonio, TX: Psychological Corporation.
23. Denckla, M. B. (1989). Executive function, the overlap zone between attention deficit hyperactivity disorder and learning disabilities. International Pediatrics, 4, 155-160.
24. Denckla, M. B. (1994). Measurement of executive function. In G. R. Lyon (Ed.), Frames of reference for the assessment of learning disabilities: New views on measurement issues. Baltimore: Paul Brookes.
25. Denckla, M. B., & Reiss, A. L. (1997). Prefrontal-subcortical circuits in developmental disorders. In N. A. Krasnegor, G. R. Lyon, & P. S. Goldman-Rakic (Eds.), Development of the prefrontal cortex: Evolution, neurobiology and behavior (pp. 283-294). Baltimore: Paul H. Brookes.
26. Diamond, A., Prevor, M. B., Callender, G., & Druin, D. P. (1997). Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monographs of the Society for Research in Child Development, 62(4), 1-208.
27. DuPaul, G. J., Anastopoulos, A. D., Power, T. J., Reid, R., Ikeda, M., & McGoey, K. E. (1998). Parent ratings of attention-deficit/ hyperactivity disorder: Factor structure, normative data, and psychometric properties. Journal of Psychopathology & Behavioral Assessment, 20, 83-102.
28. Dyer, C. A. (1999). Pathophysiology of phenylketonuria. Mental Retardation and Developmental Disabilities Research Reviews, 5, 104-112.
29. Fuster, J. M. (1985). The prefrontal cortex, mediator of cross-temporal contingencies. Human Neurobiology, 4, 169-179.
30. Gansler, D. A., Fucetola, R., Krengel, M., Stetson, S., Zimering, R., & Makary, C. (1998). Are there cognitive subtypes in adult attention deficit/hyperactivity disorder? Journal of Nervous & Mental Disease, 186, 776-781.
31. Gioia, G. A. (1993). The tower of Hanoi task and developmental executive dysfunction. Journal of Clinical and Experimental Neuropsychology, 15, 88.
32. Gioia, G. A., Isquith, P. K., Guy, S. C., & Kenworthy, L. (2000). BRIEF: Behavior Rating Inventory of Executive Function. Odessa, FL: Psychological Assessment Resources.
33. Golden, J. C. (1978). Stroop Color and Word Test. Chicago: Stoelting.
34. Goldman-Rakic, P. S. (1987). Circuitry of the primate prefrontal cortex and the regulation of behaviour by representational memory. In F. Plum (Ed.), Handbook of physiology: The nervous system: Vol. V. Higher functions of the brain (pp. 373-417). Baltimore: American Physiological Society.
35. Gourovitch, M. L., Craft, S., Dowton, S. B., Ambrose, P., & Sparta, S. (1994). Interhemispheric transfer in children with early-treated phenylketonuria. Journal of Clinical and Experimental Neuropsychology, 16, 393-404.
36. Graf, P., Uttl, B., & Tuokko, H. (1995). Color- and picture-word Stroop tests: Performance changes in old age. Journal of Clinical and Experimental Neuropsychology, 17, 390-415.
37. Hanes, K. R., Andrewes, D. G., Smith, D. J., & Pantelis, C. (1996). A brief assessment of executive control dysfunction: Discriminant validity and homogeneity of planning, set shift, and fluency measures. Archives of Clinical Neuropsychology, 11, 185-191.
38. Henik, A. (1996). Paying attention to the Stroop effect. Journal of the International Neuropsychological Society, 2, 467-470.
39. Holmes-Bernstein, J., & Waber, D. P. (1996). Developmental scoring system for the Rey-Osterrieth complex figure. Odessa, FL: Psychological Assessment Resources.
40. Isquith, P. K., & Gioia, G. A. (1999). The nature of executive function in ADHD. The Clinical Neuropsychologist, 13, 222.
41. Kaplan, E. (1976, September). The role of non-compromised hemisphere in patients with local brain disease. In H. L. Teuber (Chair), Alterations in brain functioning and changes in cognition. Symposium conducted at the 84th Annual Convention of the American Psychological Association, Washington, DC.
42. Kaplan, E., Goodglass, H., & Weintraub, S. (1983). The Boston Naming Test (2nd ed.). Philadelphia: Lea & Febiger.
43. Kimko, H. C., Cross, J. T., & Abernethy, D. R. (1999). Pharmacokinetics and clinical effectiveness of methylphenidate. Clinical Pharmacokinetics, 37, 457-470.
44. Klorman, R., Hazel-Fernandez, L. A., Shaywitz, S. E., Fletcher, J. M., Marchione, K. E., Holahan, J. M., et al. (1999). Executive functioning deficits in attention-deficit/hyperactivity disorder are independent of oppositional defiant or reading disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 38, 1148-1155.
45. Kovacs, M. (1992). Children's Depression Inventory. North Tonawanda, NY: Multi-Health Systems.
46. Krause, W., Halminski, M., McDonald, L., Dembure, P., Salvo, R., Freides, D., & Elsas, L. (1985). Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria: A model for the study of phenylalanine and brain function in man. Journal of Clinical Investigation, 75, 40-48.
47. Lenke, R. R., & Levy, H. L. (1980). Maternal phenylketonuria and hyperphenylalaninemia: An international survey of the outcome of untreated and treated pregnancies. New England Journal of Medicine, 303, 1202-1208.
48. Levy, H. L., & Ghavami, M. (1996). Maternal phenylketonuria: A metabolic teratogen. Teratology, 53, 176-184.
49. Levy, H. L., Lobbregt, D., Barnes, P. D., & Poussaint, T. Y. (1996). Maternal phenylketonuria: Magnetic resonance imaging of the brain in offspring. Journal of Pediatrics, 128, 770-775.
50. Lou, H. C., Guttler, F., Lykkelund, C., Bruhn, P., & Niederwieser, A. (1985). Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents. European Journal of Pediatrics, 144, 17-20.
51. Lou, H. C., Toft, P. B., Andresen, J., Mikkelsen, I., Olsen, B., Guttler, F., et al. (1992). An occipito-temporal syndrome in adolescents with optimally controlled hyperphenylalaninaemia. Journal of Inherited Metabolic Disease, 15, 687-695.
52. MacLeod, C. M. (1991). Half a century of research on the Stroop effect: An integrative review. Psychological Bulletin, 109, 163-203.
53. Mirsky, A. F. (1996). Disorders of attention: A neuropsychological perspective. In G. Lyon, & N. Krasnegor (Eds.), Attention, memory, and executive function (pp. 71-95). Baltimore: Paul H. Brookes.
54. Morgan, A. E., Hynd, G. W., Riccio, C. A., & Hall, J. (1996). Validity of DSM-IV ADHD predominantly inattentive and combined types: Relationship to previous DSM diagnoses/subtype differences. Journal of the American Academy of Child & Adolescent Psychiatry, 35, 325-333.
55. National Institutes of Health. (2000). Phenylketonuria (PKU): Screening and management. NIH Consensus Statement, 17(3), 1-33.
56. Nigg, J. T. (2001). Is ADHD a disinhibitory disorder? Psychological Bulletin, 127, 571-598.
57. Nigg, J. T., Blaskey, L., Huang, C., & Rappley, M. (2000). Executive functioning and ADHD DSM-IV subtypes. Manuscript submitted for publication.
58. Pearsen, K. D., Gean-Marton, A. D., Levy, H. L., & Davis, K. R. (1990). Phenylketonuria: MR imaging of the brain with clinical correlation. Radiology, 177, 437-440.
59. Pennington, B. F. (1991). Diagnosing learning disorders. New York: Guilford Press.
60. Pennington, B. F. (1997). Dimensions of executive functions in normal and abnormal development. In N. A. Krasnegor, G. R. Lyon, & P. S. Goldman-Rakic (Eds.), Development of the prefrontal cortex: Evolution, neurobiology and behavior (pp. 265-282). Baltimore: Paul H. Brookes.
61. Pennington, B. F., Bennetto, L., McAleer, O. K., & Roberts, R. J. (1996). Executive functions and working memory: Theoretical and measurement issues. In G. R. Lyon & N. A. Krasnegor (Eds.), Attention, memory and executive function (pp. 198-228). Baltimore: Paul H. Brookes.
62. Pietz, J., Fatkenheuer, B., Burgard, P., Armbruster, M., Esser, G., & Schmidt, H. (1997). Psychiatric disorders in adult patients with early-treated phenylketonuria. Pediatrics, 99, 345-350.
63. Pietz, J., Kreis, R., Rupp, A., Mayatepek, E., Rating, D., Boesch, C., & Bremer, H. J. (1999). Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. Journal of Clinical Investigation, 103, 1169-1178.
64. Power, T. J., Andrews, T. J., Eiraldi, R. B., Doherty, B. J., Ikeda, M. J., DuPaul, G. J., & Landau, S. (1998). Evaluating attention deficit hyperactivity disorder using multiple informants: The incremental utility of combining teacher with parent reports. Psychological Assessment, 10, 250-260.
65. Reiber, R. W., & Carton, A. S. (1987). The collected works of L. S. Vygotsky, (Vol. 1). New York: Plenum Press.
66. Rey, A. (1941). Psychological examination of traumatic encephalopathy. Archives de Psychologie, 28, 286-340.
67. Reynolds, W. M. (1992). Depression in children and adolescents. In W. M. Reynolds (Ed.), Internalizing disorders in children and adolescents (pp. 149-253). New York: Wiley.
68. Rice, D., & Barone, S. J. (2000). Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models. Environmental Health Perspectives, 103(Suppl. 3), 511-533.
69. Ris, M. D., Williams, S. E., Hunt, M. M., Berry, H. K., & Leslie, N. (1994). Early-treated phenylketonuria: Adult neuropsychologic outcome. Journal of Pediatrics, 124, 388-392.
70. Sattler, J. M. (2001). Assessment of children: Cognitive applications (4th ed.). San Diego, CA: Sattler.
71. Schmidt, E., Rupp, A., Burgard, P., Pietz, J., Weglage, J., & de Sonneville, L. (1994). Sustained attention in adult phenylketonuria: The influence of the concurrent phenylalanine-blood-level. Journal of Clinical and Experimental Neuropsychology, 16, 681-688.
72. Scriver, C. R., Kaufman, S., Eisensmith, R. C., & Woo, S. L. C. (1995). The hyperphenylalaninemias. In C. R. Scriver, A. L., Beaudet, W. S. Sly, & D. Valle (Eds.), The metabolic and molecular bases of inherited disease (7th ed., pp. 1015-1075). New York: McGraw-Hill.
73. Smith, D. W. (1982). Maternal PKU fetal effects. In D. W. Smith (Ed.), Recognizable patterns of human malformation (3rd ed., pp. 580-582). Philadelphia: Saunders.
74. Smith, M. L., Klim, P., Mallozzi, E., & Hanley, W. B. (1996). A test of the frontal-specificity hypothesis in the cognitive performance of adults with phenylketonuria. Developmental Neuropsychology, 12, 327-341.
75. Stuss, D. T. (1992). Biological and psychological development of executive functions. Brain & Cognition, 20, 8-23.
76. Taylor, E. M. (1959). The appraisal of children with cerebral deficits. Cambridge, MA: Harvard University Press.
77. Teeter, P. A., & Semrud-Clikeman, M. (1997). Child neuropsychology. Boston: Allyn & Bacon.
78. Waisbren, S. E. (1999a). Developmental and neuropsychological outcome in children born to mothers with phenylketonuria. Mental Retardation and Developmental Disabilities Research Review, 5, 125-131.
79. Waisbren, S. E. (1999b). Phenylketonuria. In S. Goldstein & C. R. Reynolds (Eds.), Handbook of neurodevelopmental and genetic disorders in children (pp. 433-458). New York: Guilford Press.
80. Waisbren, S. E., Brown, M. J., deSonneville, L. M. J., & Levy, H. L. (1994). Review of neuropsychological functioning in treated phenylketonuria: An information processing approach. Acta Paediatrica, 407(Suppl.), 98-103.
81. Waisbren, S. E., Hanley, W., Levy, H. L., Shifrin, H., Allred, E., Azen, C., et al. (2000). Outcome at age 4 years in offspring of women with maternal phenylketonuria: The Maternal PKU Collaborative Study. Journal of the American Medical Association, 283, 756-762.
82. Walsh, K. W. (1994). Neuropsychology: A clinical approach. New York: Churchill Livingstone.
83. Wechsler, D. (1991). Wechsler Intelligence Scale for Children (3rd ed.). New York: Psychological Corporation.
84. Weglage, J., Pietsch, M., Funders, B., Koch, H. G., & Ullrich, K. (1996). Deficits in selective and sustained attention processes in early treated children with phenylketonuria: Result of impaired frontal lobe functions? European Journal of Pediatrics, 155, 200-204.
85. Welsh, M. C., & Pennington, B. F. (1988). Assessing frontal lobe functioning in children: Views from developmental psychology. Developmental Neuropsychology, 4, 199-230.
86. Welsh, M. C., Pennington, B. F., Ozonoff, S., Rouse, B., & McCabe, E. R. B. (1990). Neuropsychology of early treated phenylketonuria: Specific executive function deficits. Child Development, 61, 1697-1713.
87. White, D. A., Nortz, M. J., Mandernach, T., Huntington, K., & Steiner, R. D. (2001). Deficits in memory strategy use related to prefrontal dysfunction during early development: Evidence from children with phenylketonuria. Neuropsychology, 15, 221-229.
88. White, D. A., Nortz, M. J., Mandemach, T., Huntington, K., & Steiner, R. D. (2002). Age-related working memory impairments in children with prefrontal dysfunction associated with phenylketonuria. Journal of the International Neuropsychological Society, 8, 1-11.
89. Yakovlev, P. I. (1962). Morphological criteria of growth and maturation of the nervous system in man. Research Publication of the Association for Research on Nervous and Mental Disease, 39, 3-46.